{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:06:05Z","timestamp":1759017965858,"version":"3.44.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.annder.2019.09.606","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T09:46:24Z","timestamp":1576662384000},"page":"212-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Isch\u00e9mie digitale avec ulc\u00e9ration pulpaire sous ipilimumab"],"prefix":"10.1016","volume":"147","author":[{"given":"N.","family":"Zenati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Templier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Blaise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2019.09.606_bib0075","first-page":"61","article-title":"Digital ischemia revealing multiple myeloma","author":"Khammar","year":"2018","journal-title":"J Med Vasc"},{"key":"10.1016\/j.annder.2019.09.606_bib0080","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/MD.0000000000000047","article-title":"Digital ischemia associated with cancer: results from A Cohort Study","volume":"93","author":"Le Besnerais","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.annder.2019.09.606_bib0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0398-0499(05)83795-3","article-title":"Digital ischaemia and gemcitabine. Two new cases","author":"Blaise","year":"2005","journal-title":"J Mal Vasc"},{"key":"10.1016\/j.annder.2019.09.606_bib0090","article-title":"Digital ischemia as an unusual manifestation of Hodgkin's Lymphoma","volume":"19","author":"Villano","year":"2018","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.annder.2019.09.606_bib0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40425-018-0321-2","article-title":"Ipilimumab induced digital vasculitis","volume":"6","author":"Padda","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.annder.2019.09.606_bib0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s40425-018-0443-6","article-title":"Immune checkpoint inhibitor-related acral vasculitis","volume":"6","author":"Comont","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.annder.2019.09.606_bib0105","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jdcr.2018.05.020","article-title":"Checkpoint inhibitor-associated cutaneous small vessel vasculitis","volume":"11","author":"Castillo","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.annder.2019.09.606_bib0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12885-017-3313-6","article-title":"Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade","volume":"17","author":"Gambichler","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.annder.2019.09.606_bib0115","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1007\/s10067-018-4177-0","article-title":"Vasculitis associated with immune checkpoint inhibitors-a systematic review","volume":"37","author":"Daxini","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.annder.2019.09.606_bib0120","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1159\/000492463","article-title":"Thromboembolic events related to treatment with checkpoint inhibitors: Report of two cases","volume":"11","author":"Tsukamoto","year":"2018","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.annder.2019.09.606_bib0125","first-page":"1110","article-title":"New melanoma immunotherapies: mechanisms of action, efficiency and management of toxicities","volume":"11","author":"Moura","year":"2015","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.annder.2019.09.606_bib0130","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s40265-018-0945-z","article-title":"Metastatic melanoma: recent therapeutic progress and future perspectives","volume":"78","author":"Grob","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.annder.2019.09.606_bib0135","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1684\/bdc.2014.2054","article-title":"Immunotherapies and melanoma","volume":"101","author":"Routier","year":"2014","journal-title":"Bull Cancer"},{"key":"10.1016\/j.annder.2019.09.606_bib0070","first-page":"139","article-title":"Anti-PD1\u00a0and anti-PD-L1\u00a0antibodies in melanoma and bronchial cancer","author":"Barlesi","year":"2017","journal-title":"Innov Ther Oncol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963819310257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963819310257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:08:19Z","timestamp":1758971299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963819310257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0151963819310257"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2019.09.606","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isch\u00e9mie digitale avec ulc\u00e9ration pulpaire sous ipilimumab","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2019.09.606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}